|
G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ABCA1 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
multiple interactions
|
ISO
|
glycitein inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; glycitein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]]; glycitein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]
|
CTD |
PMID:34217736 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
G
|
Acsl3
|
acyl-CoA synthetase long-chain family member 3
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
|
|
G
|
Add2
|
adducin 2
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ADD2 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 4:120,001,977...120,101,090
Ensembl chr 4:120,002,054...120,101,091
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
increases activity
|
ISO
|
glycitein results in increased activity of AHR protein
|
CTD |
PMID:17869316 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
G
|
Aldh1a2
|
aldehyde dehydrogenase 1 family, member A2
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ALDH1A2 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883
|
|
G
|
Anpep
|
alanyl aminopeptidase, membrane
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ANPEP mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101
|
|
G
|
Arhgdia
|
Rho GDP dissociation inhibitor alpha
|
decreases expression
|
ISO
|
glycitein results in decreased expression of ARHGDIA mRNA
|
CTD |
PMID:15757668 |
|
NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347
|
|
G
|
Atoh8
|
atonal bHLH transcription factor 8
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of ATOH8 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379
|
|
G
|
Atp6v0a2
|
ATPase H+ transporting V0 subunit a2
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ATP6V0A2 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr12:37,608,211...37,640,860
Ensembl chr12:37,472,813...37,640,860
|
|
G
|
Baz1a
|
bromodomain adjacent to zinc finger domain, 1A
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648
|
|
G
|
Bckdk
|
branched chain ketoacid dehydrogenase kinase
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of BCKDK mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453
|
|
G
|
Bpgm
|
bisphosphoglycerate mutase
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of BPGM mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:64,106,804...64,135,627
|
|
G
|
Cabp5
|
calcium binding protein 5
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CABP5 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:83,486,396...83,499,421
Ensembl chr 1:83,486,396...83,499,421
|
|
G
|
Cacybp
|
calcyclin binding protein
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505
|
|
G
|
Casp8ap2
|
caspase 8 associated protein 2
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:51,810,972...51,848,632
|
|
G
|
Ccna2
|
cyclin A2
|
decreases expression
|
ISO
|
glycitein results in decreased expression of CCNA2
|
CTD |
PMID:21161820 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
G
|
Ccnd1
|
cyclin D1
|
increases expression
|
ISO
|
glycitein results in increased expression of CCND1 mRNA
|
CTD |
PMID:19800779 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Cd200r1
|
CD200 receptor 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CD200R1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr11:69,392,943...69,427,213
Ensembl chr11:69,392,975...69,427,128
|
|
G
|
Cdk4
|
cyclin-dependent kinase 4
|
decreases activity
|
ISO
|
glycitein results in decreased activity of CDK4 protein
|
CTD |
PMID:21161820 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
ISO
|
ESR2 affects the reaction [glycitein results in increased expression of CDKN1A]
|
CTD |
PMID:21161820 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cfap251
|
cilia and flagella associated protein 251
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CFAP251 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr12:38,923,154...38,997,881
Ensembl chr12:38,922,330...38,954,783
|
|
G
|
Cybrd1
|
cytochrome b reductase 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 3:76,342,231...76,369,846
Ensembl chr 3:76,342,404...76,370,061
|
|
G
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of CYP11A1 mRNA
|
CTD |
PMID:28964809 |
|
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
|
|
G
|
Dennd2d
|
DENN domain containing 2D
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 2:196,661,465...196,680,505
Ensembl chr 2:196,661,345...196,682,397
|
|
G
|
Dnmt1
|
DNA methyltransferase 1
|
multiple interactions
|
EXP
|
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT1 mRNA
|
CTD |
PMID:28964809 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
G
|
Dnmt3a
|
DNA methyltransferase 3 alpha
|
multiple interactions
|
EXP
|
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA
|
CTD |
PMID:28964809 |
|
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970
|
|
G
|
Dock3
|
dedicator of cyto-kinesis 3
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of DOCK3 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 8:116,431,158...116,782,218
Ensembl chr 8:116,431,159...116,782,195
|
|
G
|
Dpp9
|
dipeptidyl peptidase 9
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 9:1,098,505...1,133,500
Ensembl chr 9:1,095,929...1,177,715
|
|
G
|
Edrf1
|
erythroid differentiation regulatory factor 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of EDRF1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:188,441,514...188,478,743
Ensembl chr 1:197,870,962...197,908,731
|
|
G
|
Efhd1
|
EF-hand domain family, member D1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of EFHD1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798
|
|
G
|
Epha1
|
Eph receptor A1
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474
|
|
G
|
Espn
|
espin
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ESPN mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:167,909,271...167,942,984
|
|
G
|
Esr1
|
estrogen receptor 1
|
multiple interactions affects binding
|
ISO
|
glycitein inhibits the reaction [Estradiol binds to ESR1 protein] glycitein binds to ESR1 protein
|
CTD |
PMID:14579009 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Esr2
|
estrogen receptor 2
|
multiple interactions affects response to substance
|
ISO EXP
|
ESR2 affects the reaction [glycitein results in increased expression of CDKN1A] ESR2 affects the susceptibility to glycitein [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of ESR2 mRNA
|
CTD |
PMID:21161820 PMID:28964809 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
G
|
Fam171a2
|
family with sequence similarity 171, member A2
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of FAM171A2 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr10:87,393,888...87,404,051
Ensembl chr10:87,893,543...87,904,247
|
|
G
|
Fam180a
|
family with sequence similarity 180, member A
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM180A mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 4:64,959,999...64,975,176
Ensembl chr 4:64,959,999...64,975,176
|
|
G
|
Fam210b
|
family with sequence similarity 210, member B
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 3:181,536,665...181,546,830
Ensembl chr 3:181,536,673...181,546,834
|
|
G
|
Fam241b
|
family with sequence similarity 241 member B
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,595,084...30,597,844 Ensembl chr 6:30,595,084...30,597,844
|
|
G
|
Fgd6
|
FYVE, RhoGEF and PH domain containing 6
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of FGD6 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 7:30,484,600...30,599,898
Ensembl chr 7:30,484,600...30,595,806
|
|
G
|
Fhl2
|
four and a half LIM domains 2
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FHL2 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326
|
|
G
|
Fmn2
|
formin 2
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of FMN2 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr13:88,986,863...89,303,789
Ensembl chr13:88,986,842...89,303,789
|
|
G
|
Galnt15
|
polypeptide N-acetylgalactosaminyltransferase 15
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr16:7,233,524...7,273,290
Ensembl chr16:7,233,606...7,273,285
|
|
G
|
Gng5
|
G protein subunit gamma 5
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of GNG5 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 2:238,054,954...238,063,451
Ensembl chr11:58,096,362...58,096,565 Ensembl chr 2:58,096,362...58,096,565
|
|
G
|
Hipk4
|
homeodomain interacting protein kinase 4
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of HIPK4 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:91,938,308...91,948,680
Ensembl chr 1:91,938,278...91,948,683
|
|
G
|
Hmcn1
|
hemicentin 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of HMCN1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr13:65,165,532...65,634,681
Ensembl chr13:65,165,532...65,634,519
|
|
G
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
multiple interactions
|
EXP
|
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of HSD3B1 mRNA
|
CTD |
PMID:28964809 |
|
NCBI chr 2:188,858,574...188,864,694
|
|
G
|
Ifrd2
|
interferon-related developmental regulator 2
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IFRD2 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836
|
|
G
|
Il6r
|
interleukin 6 receptor
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of IL6R mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
|
|
G
|
Irf2bp1
|
interferon regulatory factor 2 binding protein 1
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IRF2BP1 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 1:78,652,736...78,655,437
Ensembl chr 1:87,779,406...87,785,661
|
|
G
|
Isg20l2
|
interferon stimulated exonuclease gene 20-like 2
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ISG20L2 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 2:173,396,780...173,407,102
Ensembl chr 2:175,695,615...175,705,095
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases activity
|
ISO
|
glycitein results in increased activity of JUN protein
|
CTD |
PMID:17088408 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
G
|
Kcng2
|
potassium voltage-gated channel modifier subfamily G member 2
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of KCNG2 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr18:76,017,225...76,085,377
Ensembl chr18:76,018,047...76,083,688
|
|
G
|
Kdm5a
|
lysine demethylase 5A
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 4:155,238,124...155,316,121
Ensembl chr 4:155,238,044...155,316,121
|
|
G
|
Kitlg
|
KIT ligand
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
G
|
Knstrn
|
kinetochore-localized astrin/SPAG5 binding protein
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 3:126,254,633...126,274,412
Ensembl chr 3:126,254,663...126,274,418
|
|
G
|
Ldlrap1
|
low density lipoprotein receptor adaptor protein 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LDLRAP1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 5:152,239,296...152,262,290
Ensembl chr 5:152,229,505...152,262,290
|
|
G
|
Lmod1
|
leiomodin 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LMOD1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116
|
|
G
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of LRG1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:1,034,679...1,037,337
|
|
G
|
Lsr
|
lipolysis stimulated lipoprotein receptor
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LSR mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases phosphorylation
|
ISO
|
glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] glycitein results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:17088408 PMID:20188714 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation
|
ISO
|
glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] glycitein results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:17088408 PMID:20188714 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mmp3
|
matrix metallopeptidase 3
|
decreases expression
|
ISO
|
glycitein results in decreased expression of MMP3 mRNA; glycitein results in decreased expression of MMP3 protein
|
CTD |
PMID:20188714 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions decreases expression
|
ISO
|
glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] glycitein results in decreased expression of MMP9 mRNA; glycitein results in decreased expression of MMP9 protein
|
CTD |
PMID:20188714 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Mrpl33
|
mitochondrial ribosomal protein L33
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of MRPL33 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 6:30,545,794...30,553,987
Ensembl chr 6:30,545,794...30,553,987
|
|
G
|
Mtmr11
|
myotubularin related protein 11
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of MTMR11 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 2:186,410,851...186,421,024
Ensembl chr 2:186,412,291...186,421,026
|
|
G
|
Myof
|
myoferlin
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:245,086,109...245,234,768
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions decreases activity
|
ISO
|
glycitein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; glycitein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] glycitein results in decreased activity of NOS2 protein
|
CTD |
PMID:11308324 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041
|
|
G
|
Nr5a1
|
nuclear receptor subfamily 5, group A, member 1
|
multiple interactions
|
EXP
|
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 mRNA; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 protein; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased methylation of NR5A1 promoter; decitabine inhibits the reaction [[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 mRNA]
|
CTD |
PMID:28964809 |
|
NCBI chr 3:42,874,505...42,896,109
Ensembl chr 3:42,875,221...42,896,046
|
|
G
|
Nrip1
|
nuclear receptor interacting protein 1
|
increases expression
|
ISO
|
glycitein results in increased expression of NRIP1 mRNA
|
CTD |
PMID:15757668 |
|
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:28,378,878...28,467,353
|
|
G
|
Olfml3
|
olfactomedin-like 3
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of OLFML3 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:193,932,665...193,935,494
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression
|
ISO
|
glycitein results in decreased expression of PCNA
|
CTD |
PMID:21161820 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
G
|
Pdlim2
|
PDZ and LIM domain 2
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PDLIM2 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr15:51,647,195...51,659,904
Ensembl chr15:51,647,197...51,658,958
|
|
G
|
Pnn
|
pinin, desmosome associated protein
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PNN mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 6:82,493,032...82,501,345
Ensembl chr 6:82,492,978...82,501,933
|
|
G
|
Pou4f2
|
POU class 4 homeobox 2
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of POU4F2 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr19:46,390,958...46,394,599
Ensembl chr19:46,390,958...46,394,599
|
|
G
|
Prkaca
|
protein kinase cAMP-activated catalytic subunit alpha
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494
|
|
G
|
Prpf40a
|
pre-mRNA processing factor 40 homolog A
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of PRPF40A mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 3:58,036,779...58,098,996
Ensembl chr 3:58,038,042...58,099,363
|
|
G
|
Pspc1
|
paraspeckle component 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of PSPC1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr15:34,941,445...35,027,460
Ensembl chr15:34,967,477...35,026,828
|
|
G
|
Pth1r
|
parathyroid hormone 1 receptor
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of PTH1R mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 8:119,572,295...119,597,405
Ensembl chr 8:119,575,868...119,598,108
|
|
G
|
Rassf5
|
Ras association domain family member 5
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of RASSF5 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr13:45,189,768...45,255,277
Ensembl chr13:45,189,804...45,255,277
|
|
G
|
Rgs22
|
regulator of G-protein signaling 22
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of RGS22 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 7:69,073,681...69,194,041
Ensembl chr 7:69,075,562...69,194,102
|
|
G
|
Rps6ka3
|
ribosomal protein S6 kinase A3
|
increases expression
|
ISO
|
glycitein results in increased expression of RPS6KA3 mRNA
|
CTD |
PMID:15757668 |
|
NCBI chr X:39,325,926...39,432,017
Ensembl chr X:39,325,926...39,433,678
|
|
G
|
S1pr3
|
sphingosine-1-phosphate receptor 3
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr17:13,932,773...13,946,213
Ensembl chr17:13,928,444...13,947,197
|
|
G
|
Selplg
|
selectin P ligand
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SELPLG mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr12:48,457,102...48,470,444
Ensembl chr12:48,456,932...48,473,154
|
|
G
|
Sgpp1
|
sphingosine-1-phosphate phosphatase 1
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of SGPP1 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 6:100,161,024...100,182,214
Ensembl chr 6:100,161,024...100,182,259
|
|
G
|
Siglec10
|
sialic acid binding Ig-like lectin 10
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of SIGLEC10 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:93,817,301...93,826,376
Ensembl chr 1:102,953,918...102,962,964
|
|
G
|
Slc12a2
|
solute carrier family 12 member 2
|
decreases expression
|
ISO
|
glycitein results in decreased expression of SLC12A2 mRNA
|
CTD |
PMID:15757668 |
|
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
|
|
G
|
Slc16a1
|
solute carrier family 16 member 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:194,812,502...194,832,977
|
|
G
|
Slc22a8
|
solute carrier family 22 member 8
|
increases uptake
|
ISO
|
SLC22A8 protein results in increased uptake of glycitein analog
|
CTD |
PMID:21244849 |
|
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
|
|
G
|
Snx30
|
sorting nexin family member 30
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of SNX30 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 5:79,478,804...79,608,118
Ensembl chr 5:79,478,912...79,607,052
|
|
G
|
Sp1
|
Sp1 transcription factor
|
multiple interactions increases activity
|
ISO
|
glycitein promotes the reaction [SP1 protein binds to VDR promoter]; U 0126 inhibits the reaction [glycitein results in increased activity of SP1 protein]
|
CTD |
PMID:17088408 |
|
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513
|
|
G
|
Ssc5d
|
scavenger receptor cysteine rich family member with 5 domains
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SSC5D mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 1:77,920,781...77,939,284
Ensembl chr 1:77,920,783...77,938,574
|
|
G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions
|
EXP
|
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of STAR mRNA; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of STAR protein
|
CTD |
PMID:28964809 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
G
|
Stc1
|
stanniocalcin 1
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of STC1 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082
|
|
G
|
Styxl1
|
serine/threonine/tyrosine interacting-like 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr12:26,544,059...26,576,365
Ensembl chr12:26,544,067...26,576,366
|
|
G
|
Sumo1
|
small ubiquitin-like modifier 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of SUMO1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 9:68,572,901...68,602,803
Ensembl chr 9:68,572,911...68,602,890
|
|
G
|
Tacr3
|
tachykinin receptor 3
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of TACR3 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 2:225,940,497...226,037,756
Ensembl chr 2:225,940,444...226,037,756
|
|
G
|
Tc2n
|
tandem C2 domains, nuclear
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of TC2N mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 6:126,526,006...126,622,163
Ensembl chr 6:126,526,009...126,614,215
|
|
G
|
Tnfaip6
|
TNF alpha induced protein 6
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of TNFAIP6 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression
|
ISO
|
glycitein results in increased expression of TP53 protein
|
CTD |
PMID:19800779 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Tp53i11
|
tumor protein p53 inducible protein 11
|
decreases expression multiple interactions
|
ISO
|
glycitein results in decreased expression of TP53I11 mRNA [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of TP53I11 mRNA
|
CTD |
PMID:15757668 PMID:27424125 |
|
NCBI chr 3:99,600,213...99,615,462
Ensembl chr 3:99,600,159...99,615,432
|
|
G
|
Uchl1
|
ubiquitin C-terminal hydrolase L1
|
multiple interactions
|
ISO
|
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of UCHL1 mRNA
|
CTD |
PMID:16963248 |
|
NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417
|
|
G
|
Vcpip1
|
valosin containing protein interacting protein 1
|
multiple interactions
|
ISO
|
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of VCPIP1 mRNA
|
CTD |
PMID:27424125 |
|
NCBI chr 5:14,317,083...14,343,724
Ensembl chr 5:14,316,918...14,347,778
|
|
G
|
Vdr
|
vitamin D receptor
|
multiple interactions increases expression
|
ISO
|
fulvestrant inhibits the reaction [glycitein results in increased expression of VDR protein]; glycitein promotes the reaction [SP1 protein binds to VDR promoter]; U 0126 inhibits the reaction [glycitein results in increased expression of VDR protein] glycitein results in increased expression of VDR mRNA; glycitein results in increased expression of VDR protein
|
CTD |
PMID:17088408 |
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|